AFFiRiS AG-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:AFFiRiS AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011786
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥26,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥53,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥80,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Affiris AG (AFFiRiS) is a drug development company that develops and manufactures novel synthetic vaccines against chronic diseases. The company develops customized peptide vaccines based on its proprietary affitome technology for the prevention of Alzheimer’s disease, Parkinson’s disease, atherosclerosis, multiple system atrophy, diabetes and other diseases. Its pipeline products comprise PCSK9; a-Syn PD01/PD03, PD04; Ab AD05, HTT and IgE. The company offers its technologies and services to the customers across Austria, Albania, Bosnia-Herzegovina, Canada, Croatia, Macedonia, Australia, Russia, Romania, Serbia, the US and Belarus. AFFiRiS is headquartered in Vienna, Austria.

AFFiRiS AG – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
AFFiRiS AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
AFFiRiS AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
AFFiRiS AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
AFFiRiS AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
AFFiRiS AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
AFFiRiS AG, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
AFFiRiS Raises USD11.4 Million in Venture Financing 10
AFFiRiS Secures US$34 Million In Venture Financing 11
Partnerships 12
AFFiRiS Enters Into Co-Development Agreement With Medical University Of Vienna 12
Licensing Agreements 13
AFFiRiS Extends Licensing Agreement With GlaxoSmithKline 13
Equity Offering 14
AFFiRiS Raises USD11.3 Million in Equity Financing 14
AFFiRiS AG – Key Competitors 15
AFFiRiS AG – Key Employees 16
AFFiRiS AG – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
AFFiRiS AG, Pharmaceuticals & Healthcare, Key Facts 2
AFFiRiS AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
AFFiRiS AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
AFFiRiS AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
AFFiRiS AG, Deals By Therapy Area, 2011 to YTD 2017 8
AFFiRiS AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
AFFiRiS Raises USD11.4 Million in Venture Financing 10
AFFiRiS Secures US$34 Million In Venture Financing 11
AFFiRiS Enters Into Co-Development Agreement With Medical University Of Vienna 12
AFFiRiS Extends Licensing Agreement With GlaxoSmithKline 13
AFFiRiS Raises USD11.3 Million in Equity Financing 14
AFFiRiS AG, Key Competitors 15
AFFiRiS AG, Key Employees 16

★海外企業調査レポート[AFFiRiS AG-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • CLC bio:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' CLC bio Mergers and Acquisition …
  • United Capital Financial Partners, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' United Capital Financial Partne …
  • Omnitech Infosolutions Limited (OMNITECH):企業財務及び戦略的SWOT分析
    Summary Omnitech Infosolutions Limited (Omnitech Infosolutions) is an technology company that provides information technology (IT) solutions. The company’s services include infrastructure management services, application development, application management, testing, disaster recovery, business conti …
  • Total Petrochemicals & Refining USA, Inc:企業の戦略的SWOT分析
    Total Petrochemicals & Refining USA, Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Las Vegas Sands Corp.:企業の戦略・SWOT・財務分析
    SummaryLas Vegas Sands Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key F …
  • Leroy Seafood Group ASA:企業の戦略・SWOT・財務情報
    Leroy Seafood Group ASA - Strategy, SWOT and Corporate Finance Report Summary Leroy Seafood Group ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Eastern Insurance Acquisition Group:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Eastern Insurance Acquisition G …
  • PHINMA Energy Corp (TAPET):企業のM&A・提携動向(石油・ガス分野)
    Summary PHINMA Energy Corp (PHINMA), formerly known as Trans-Asia Oil and Energy Development Corporation, is an oil and gas company that explores and develops oil and gas interest and geothermal energy. The company operates through power business, wind energy and energy resource development segments …
  • Arsenal Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Arsenal Medical Inc (Arsenal) is a platform technology company that develops novel therapeutic polymer based foams. The company’s products include in-situ forming materials, in-situ forming polymeric foam and in-situ curing elastomeric polymer material. It offers in-situ forming materials to …
  • Pharmsynthez (LIFE):企業財務及び戦略的SWOT分析
    Summary Pharmsynthez is a contract research organization that carries out the research, manufacture, and distribution of generic active pharmaceutical ingredients (API). The organization offers drugs incluidng neovir, segidrin, fenasid and penkrofton used fortreating cancer, gynecology, immunodefici …
  • Carl Zeiss Meditec, Inc.:企業のM&A・提携動向(医療機器分野)
    Summary Carl Zeiss Meditec, Inc. (Carl Zeiss Meditec), a subsidiary of Carl Zeiss Meditec AG is a pharmaceutical company that offers medical technology products. The company manufactures and markets various healthcare products. Carl Zeiss Meditec provides ophthalmology and optometry products, neuros …
  • Magna International Inc.:企業のM&A・提携・投資分析
    Magna International Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Magna International Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Tsumura & Co.:企業の戦略・SWOT・財務情報
    Tsumura & Co. - Strategy, SWOT and Corporate Finance Report Summary Tsumura & Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Celsis International, Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Celsis International, Ltd. Merg …
  • Global Ports Holding PLC (GPH):企業の財務・戦略的SWOT分析
    Global Ports Holding PLC (GPH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Xactware Solutions Inc:企業の戦略的SWOT分析
    Xactware Solutions Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Esperion Therapeutics, Inc. (ESPR):企業の財務及び戦略的SWOT分析
    Summary Esperion Therapeutics, Inc. (Esperion), a subsidiary of Pfizer Inc. is a biotechnology company that develops and commercializes oral, small molecule therapies for the treatment of patients with low-density lipoprotein cholesterol and other cardiometabolic risk factors. The company’s products …
  • General Communication, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' General Communication, Inc. Mer …
  • ADC Biotechnology Ltd:企業のM&A・提携動向(医療分野)
    Summary ADC Biotechnology Ltd (ADC), formerly Reaxa Biotech Ltd, focuses on the development and commercialization of technologies to generate antibody drug conjugate (ADC) based anti-cancer drugs. The company’s patented technology, Lock-Release, is a drug purification process which helps to decrease …
  • Sitara Peroxide Limited (SPL):企業財務及び戦略的SWOT分析
    Summary Sitara Peroxide Limited (Sitara Peroxide) is a chemical company that develops and sells hydrogen peroxide. The company’s containers are equipped with a venting device in the head. Its tanker trucks are equipped with hoses and fitting for attachment to bulk storage systems. Sitara Peroxide’s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆